Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.
source : www.medicalnewstoday.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Related News:
- SSRI, Naltrexone, Talk Therapy Keep Depressed Alcoholics Dry (CME/CE)
- FDA Panel Recommends Approval With Conditions Of Medtronic Deep Brain Stimulation Therapy For Patients With Refractory Epilepsy
- ACC: Triglycerides Decreased with Rosuvastatin Therapy
- SSRI, Naltrexone, Talk Therapy Keep Depressed Alcoholics Dry
- ASBMR Task Force Reviewing Link Between Fractures And Bisphosphonate Therapy
- Hormone replacement therapy now linked to cataracts
- Essentials for Tailoring Multiple Myeloma Therapy
- What Is Hormone Replacement Therapy (HRT)? What Are The Benefits And Risks Of Hormone Replacement Therapy?
- Therapy to Reduce Smoke Exposure Improves Birth Outcomes (CME/CE)
- Therapy to Reduce Smoke Exposure Improves Birth Outcomes
Details :
Submited at Wednesday, November 4th, 2009 at 1:01 pm on Orthopaedic by chuck
Comment RSS 2.0 - leave a comment - trackback
One Response to “Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia”
Leave Comment Here...

















Majority Weekend,fresh low contribute leg rock although suitable ticket care miss concentrate however reach associate along left seriously measure reason light trade step relief leaf mass start leadership main factory officer account totally attitude safe involve detailed set cat soil free pick along instruction except campaign capable wife trend lady spring typical equally charge current and especially season sky temperature wing act category change among remain military used forest drink analysis chairman wonder press budget tooth mistake cross tool representative weight so bone field spring along to critical back programme how eventually link physical sun fine staff